|
报告购买流程 |
定购方法
① 注册订购：
点击在线订购进行报告订购
我们的服务人员将在24小时内与您联系。
② 电话订购：
拔打电话：
北京：010-51266615 010-82863480/1/2/5
24小时：13436696826
传真:010-82863486
上海：021-64871266
021-64872612
24小时：13524982235
传真:021-64872324
签订协议
可从网上下载 报告订购表或由我们传真报告订购表或订购协议。
传真:010-82863486
付款方式
① 通过银行转帐的形式支付报告购买款项
② 我们收到款项后，24小时内快递报告或者发送报告邮件
③ 款项到帐后快递发票
银行电汇：
北京：
开户行：
上海浦东发展银行北京知春路支行
帐号：91170154740001300
户名： 北京佐思信息咨询有限责任公司
联系人：张小姐
|
|
 |
|
|
您的位置：佐思研究报告和竞争情报网>>研究报告交易平台>>TMT产业>>电子及元器件 |
|
|
全球生物芯片市场研究报告——Biochips - A Global Strategic Business Report
|
|
字体【大 中
小】
|
|
纸介版价格：美元/篇
|
字数：万字
|
|
电子版价格：3950美元/篇
|
页数：282页 |
|
纸介版+电子版价格：美元
|
图表数：个
|
|
完成日期：2008-07-09
|
|
|
|
|
关键字： 全球|生物芯片|Biochips| |
联系方式：
北京：010-51266615 010-82863480/1/2/5 传真:010-82863486 上海：021-64871266 021-64872612 传真:021-64872324
[在线订购]
|
发布时间：2006.8
摘要
Countries covered: Global
This report analyzes the worldwide markets for Biochips in Millions of US$. The specific product segments analyzed are DNA Chips and Protein Chips. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 68 companies including many key and niche players worldwide such as Affymetrix, GE Healthcare/Amersham Plc, Applied Biosystems Group, Biacore International AB, Biomerieux, Caliper Technologies Corp., Cepheid, Ciphergen, Inc., Takara Bio, Inc., and Zyomyx. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
目录及图表
-A. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
Product Definitions and Scope of Study
- A. DNA Chips
- B. Protein Chips
I-B. GENERAL OVERVIEW OF BIOTECH INDUSTRY
II. EXECUTIVE SUMMARY
1. Industry Overview
- Promising Biochips Promote Biological Research
- Market Scenario across Products and Regions
- Probable Industry Directions
- Biochip Technology Spreads beyond Pharma Industry
- Protein Chips to Shape the Future
- Proteomics " Chip" into Biochip Technology
- Towards Increasing Minaturization
- European Advancements Set Diagnostic Procedures
- Competitive Scenario
- Major Participants
- Roche and Affymetrix Taste Success in the Diagnostics Market
- Protein Chip Giants
- Table 1: Leading Players in Worldwide Protein Biochips Market (2004 -2005E)- Percentage Share Breakdown of Value Sales for Biacore, Ciphergen, Clontech, Zyomyx and Others (includes corresponding Graph/Chart)
- Growing Partnerships between Pharma and Biotech Companies
- Tech Giants Join the Biochip Fray
2. Product Overview
- Biochips - Complex Blend of Biochemistry and Electronics
- Historical Perspective
- Lab-on-a-chip: An Enabled Technology
- Utility
- Evolution and Segmentation
- Differing Perspectives
- Classification of Biochips
- Manufacturing Systems Used in Biochip Manufacture
- Working of a Biochip
- A Functional Model
- Cocktail of Disparate Technically Specialized Applications
- Biochips: By-product of Multi-disciplinary Sciences
- Nanotechnology
- BioMEMS
- Microfluidics
- Micro Total Analysis System
3. Biochip And Microarray Construction
- Chip Architecture
- Essence of a Biochip
- Concept of a Microarray
- Microarray Modules
- High Degree of Automation Spurs Biochips Use
- Microfabrication Technology in Biochips made from Polymer and Plastics
- Micro-optics in Biochips
- Liquid Handling Through Micro-Dispensers
- Capillary Electrophoresis and Electrochemical Detectors
- Other Technologies
- Management of Bio-information
- Scanning
- Microarray Database Management
- Classification of DNA Chips
- General Description of Spotted cDNA Microarrays
- Spotted DNA Arrays
- Spotted cDNA Versus Spotted Oligonucleotide Arrays
- Limitations of Conventional cDNA Microarrays
- Protein Biochips
- General Applications of Protein Biochips
- Challenges in the Design of a Protein Biochip
- Limitations of Protein Chip Technology
- Advances by Companies
- Concluding Remarks for Protein Biochips
4. Applications Of Biochips
- Biochip Uses
- Biochips and Pharmaceutical Investigation
- Biochips and Medical Diagnostics
- Advantages of Biosensor Chip Technology
- Biochips and Forensics
- Biochips and Transplantation Screening
- Biochips and Identity Testing
- Biochips and Water and Environmental Testing
- Food Industry
5. Trends
- Industry Characteristics
- New Products and Players to Drive Market
- Key Forces Boosting the Industry
- Industry Structure
- Industry Challenges
- Price Dearness Pauses Biochips Growth
- Current Approaches to Biochips
- The Business of Biochips
- Technological Trends
- Sensitivity
- Microfabrication
- Density
- Integrated Chips
- Patent Trends
- Patent Applications
- Table 2: Biochips Patent Applications (2003)-Percentage Breakdown by Geographic Region for US, China, Japan, Germany, South Korea, UK and Others (includes corresponding Graph/Chart)
6. Next Generation Technology
- Microfluidics Using CD-ROM Technology
7. Product Innovations and Developments
- Affymetrix Launches GeneChip(R) Scanner
- Affymetrix Releases Chip-on-Chip Array
- DNA Chip Research Launches High Sensitivity DNA Chip
- DNA Chip Research and HitachiSoft Unveils AceGene
- Hitachi Develops RFID Sensor Chip for DNA Analysis
- Canon Develops DNA Chip on Inkjet Printer Technology
- Biacore Introduces Array-Based Protein Interaction Analysis Systems
- Caliper Launches Protein Express Assay for Electrophoresis System
- Affymetrix Rolls Out GeneChip(R) Globin-Reduction Kits and Protocol
- Biacore Introduces Next Generation System for Protein Interaction Analysis (Sweden)
- Affymetrix and Invitrogen Launch Reagents for GeneChip Expression Array Platform
- Amersham Biosciences Extends CodeLink Range
- Ciphergen Showcases ProteinChip System- Series 4000
- Affymetrix Rolls Out Plasmodium/Anopheles Genome GeneChip(R) Array
- SIRS-Lab Showcases Lab-Arraytor(R)
- Affymetrix Unveils GeneChip(R) Array for Malaria Study
- Caliper Extends Portfolio of LabChip Microfluidic Systems
- Affymetrix Launches World's First Diagnostic Microarray System (Europe)
- Ushio's biochip Machine for BioMEM and MicroTAS (Japan)
- Invitrogen Unveils Yeast ProtoArray
- Randox Showcases biochip Technology for Clinical Diagnostics (UK)
- Zyomyx Introduces Murine Cytokine Biochip (US)
- Invitrogen Launches ProtoArray Human Protein Microarray
- Affymetrix Launches Plasmodium Genome GeneChip(R)
- Recent Past Product Launches & Developments
8. Recent Industry Activity
- Toshiba Signs Licensing Agreement with Antara BioSciences
- MUSC Signs LOI with Lumera
- Biacore Expands Operations into Chinese Market
- Nisshinbo to Replace Glass with Resin in DNA Production
- OCIMUM Acquires a Division of MWG Biotech AG
- Biacore Acquires FLEXChip from HTS BioSystems
- Qiagen Acquires Assets of LumiCyte
- BD Sells Clontech
- Affymetrix Acquires ParAllele BioScience
- Biacore Acquires FLEXChip System from HTS BioSystems
- Caliper Signs Purchase Agreement with Amphora
- Bio-Rad Inks Agreement with Caliper
- Toray Enters Joint Research Agreement with DNA Chip Research
- Ciphergen and Quest Diagnostics Partner for Proteomic Diagnostic Tests
- Affymetrix and bioMerieux Extend Agreement
- Agilent Technologies Licenses Caliper's LabChip(R) Technology
- Caliper and Predicant Biosciences Forge Licensing Agreement
- IntegraGen Signs Agreement with La Ligue Nationale Contre le Cancer
- Affymetrix Supplies GeneChip Technology to Veridex
- GE Acquires Amersham PLC
- ViroLogic Merges with Aclara Biosciences
- Invitrogen Accredits Protein Chip Intellectual Property From Zyomyx
- Toshiba Collaborates with Osaka University
- Siemens, Infineon and Dr. Hintsche Plan Extended Alliance on Biochip Technology
- Intel Eyes Biochips
- APAF and LumiCyte Join Hands in Proteomic Discovery
- Affymetrix and Caliper Life Sciences Join Forces for Target Preparation
- Affymetrix and TGen Collaborate to Offer Genotyping Services
- Affymetrix Licenses GeneChip Technology to Veridex
- Affymetrix Grants Access to Aventis for GeneChip(R) Platform
- GeneChip Technology to Aid Neurological Disease Detection
- Affymetrix, ParAllele and Cambridge University Join Hands For Extensive Genotyping
- Historic Review
9. Focus on Select Global Players
- Affymetrix (US)
- GE Healthcare/Amersham Plc (UK)
- Applied Biosystems Group (US)
- Biacore International AB (Sweden)
- Biomerieux (France)
- Caliper Technologies Corp (US)
- Cepheid (US)
- Ciphergen Inc (USA)
- Takara Bio, Inc. (Japan)
- Zyomyx (US)
10. Global Market Perspective
- Table 3: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 4: World 10-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)
- Table 5: World Recent Past, Current & Future Analysis for DNA Chips by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includescorresponding Graph/Chart)
- Table 6: World 10-Year Perspective for DNA Chips by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)
- Table 7: World Recent Past, Current & Future Analysis for Protein Chips by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 8 : World 10-Year Perspective for Protein Chips by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)
III. MARKET
1. The United States
- A.Market Analysis
- Outlook
- Key Player Review
- Affymetrix
- Applied Biosystems Group
- Clontech
- Caliper Life Sciences, Inc. (Formerly Caliper Technologies Corp
- Cepheid
- Ciphergen, Inc
- Zyomyx
- Product Developments & Launches
- Strategic Corporate Developments
- B.Market Analytics
- Table 9: US Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with AnnualRevenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 10 : US 10-Year Perspective for Biochips by Product Segment- Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
2. Canada
- A.Market Analysis
- B.Market Analytics
- Table 11: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 12 : Canadian 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
3. Japan
- A.Market Analysis
- DNA Chip Based on Printing Technology
- DNA Chips to Reveal Links Among Genes
- A leading Japanese Biochip Player - Takara Shuzo
- ICAN (tm) Technology for Large-Scale Production of DNA Fragments
- Recent Product Launches
- Strategic Corporate Developments
- Takara Bio Inc - A Key Player
- B.Market Analytics
- Table 13: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 14: Japanese 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
4. Europe
- A.Market Analysis
- Biochips Outlook in Europe
- European Advancements Shape Diagnostic Procedures
- Product Launches
- B.Market Analytics
- Table 15 : European Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 16 : European 10-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, UK, and Rest of Europe Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/ Chart)
- Table 17 : European Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 18: European 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005& 2010
4a. France
- A.Market Analysis
- Key Player Review
- Biomerieux
- B.Market Analytics
- Table 19 : French Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 20 : French 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
4b. Germany
- A.Market Analysis
- Berlin, Brandenburg and Biochips
- B.Market Analytics
- Table 21 : German Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 22 : German 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
4c. The United Kingdom
- A.Market Analysis
- Product Launches
- Key Player
- GE Healthcare/Amersham Plc
- Strategic Corporate Developments -Historic
- B.Market Analytics
- Table 23 : UK Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 24 : UK 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
4d. Rest of Europe
- A.Market Analysis
- Status of Proteomics in Finland
- Key Player Review
- Biacore International AB (Sweden)
- Strategic Corporate Developments
- B.Market Analytics
- Table 25: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 26 : Rest of Europe10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
5. Rest of World
- A.Market Analysis
- China
- Basic Environment and Commercial Development
- Biochip Research
- Status of Biochip Industry in China
- Historic Review - Chinese Government Chips in
- Novel Technologies - Top on China's Agenda
- Taiwan
- Taiwan Pursues Promise of Biochip Sector
- International Advantage Sought
- Strategic Corporate Developments
- B.Market Analytics
- Table 27 : Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segments- DNA Chip and Protein chip Markets Independently Analyzed with Annual Revenues Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
- Table 28: Rest of World 10-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Revenues for DNA Chip and Protein chip Markets for Years 2000, 2005 & 2010
IV. COMPETITION
1. Abbott Molecular, Inc. (USA)
2. Advalytix AG (Germany)
3. Affymetrix, Inc. (USA)
- Table 29: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)
- Table 30: Annual Sales Analysis: 2004-2005 (In US$ million)
4. Agilent Technologies, Inc. (USA)
5. Antara Biosciences, Inc. (USA)
6. Applera Corporation (USA)
- Applied Biosystems (USA)
- Table 31: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, March) (In US$ billion)
- Table 32: Nine Months Sales Analysis by Quarter: 2005- 2006 (Nine Months Ended, March) (In US$ billion)
- Table 33: Nine Months Sales Analysis by Product Segment: 2005-2006 (Nine Months Ended, March) (In US$ billion)
- Table 34: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, March) (In US$ billion)
- Table 35: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, March) (In US$ billion)
- Table 36: Annual Sales Analysis: 2004-2005 (In US$ billion)
- Table 37: Quarterly Annual Sales Analysis: 2004-2005 (In US$ billion)
- Table 38: Annual Sales Analysis by Product Segment: 2004-2005 (In US$ billion)
- Table 39: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ billion)
- Table 40: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion) (USA))
- Celera Genomics Group (USA)
7. Array-On GmbH (Germany)
8. Aviva Bioscience Corporation (USA)
9. Biacore International AB (Sweden)
- Table 41: First Quarter Sales Analysis: 2005-2006 (Q1) (In SEK million)
- Table 42: Annual Sales Analysis: 2004-2005 (In SEK million)
- Biacore KK (Japan)
10. Bioarray Solutions LLC (USA)
11. Biochip-Imb Ltd. (Russia)
12. Biodiscovery, Inc. (USA)
13. Biomedical Photometrics, Inc. (Canada)
14. BioMérieux SA (France)
- Table 43: Nine Months Sales Analysis: 2004-2005 (In € million)
- Table 44: Nine Months Sales Analysis by Business Segment: 2004-2005 (In € million)
- Table 45: Nine Months Sales Analysis by Geographic Region: 2004-2005 (In € million)
- Table 46: Annual Sales Analysis: 2003-2004 (In € million)
- Biomerieux, Inc. (USA)
15. Bio Micro Systems (USA)
16. Bio-Rad Laboratories, Inc. (USA)
- Table 47: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)
- Table 48: First Quarter Sales Analysis by Segment: 2005-2006 (Q1) (In US$ million)
- Table 49: Annual Sales Analysis: 2004-2005 (In US$ million)
- Table 50: Quarterly Sales Analysis: 2004-2005 (In US$ million)
- Table 51: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)
- Table 52: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)
17. Caliper Life Sciences, Inc. (USA)
- Table 53: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)
- Table 54: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)
- Table 55: Annual Sales Analysis: 2004-2005 (In US$ million)
- Table 56: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)
18. Cambridge Antibody Technology (UK)
19. Cambridge Bioscience Ltd. (UK)
20. Canon Technology (Japan)
21. Cea-Leti (France)
22. Cepheid, Inc. (USA)
- Table 57: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ thousands)
- Table 58: First Quarter Sales Analysis by Segment: 2005-2006 (Q1) (In US$ thousands)
- Table 59: Annual Sales Analysis: 2004-2005 (In US$ thousands)
- Table 60: Annual Sales Analysis by Segment: 2004-2005 (In US$ thousands)
23. Chemogenix GmbH (Germany)
24. Ciphergen Biosystems, Inc. (USA)
25. Combimatrix Corporation (USA)
26. Compugen Ltd. (Israel)
27. DNA Chip Research, Inc. (Japan)
28. Epigenomics AG (Germany)
29. Febit GmbH (Germany)
30. GE Health Care - Life Sciences (USA)
31. Genescan Europe AG (Germany)
- Genescan USA, Inc. (USA)
32. Genetix Ltd. (UK)
- Genetix USA, Inc. (USA)
33. Genomic Solutions, Inc. (USA)
34. GenTel Biosurfaces, Inc. (USA)
35. Greiner Bio-One GmbH (Germany)
36. Hitachi Software Engineering Co., Limited (Japan)
- Table 61: Annual Sales Analysis: 2004-2005 (In ¥ (Yen) billion)
- Table 62: Annual Sales Analysis by Business Segment: 2004-2005 (In ¥ billion)
37. IBM Research - Nanoscale Science Department (USA)
38. Illumina, Inc. (USA)
39. Infineon Technologies AG (Germany)
40. Invitrogen Corporation (USA)
41. Jerini AG (Germany)
42. Lumera Corporation (USA)
- Table 63: First Quarter Sales Analysis: 2005-2006 (Q1) (In US$ million)
- Table 64: Annual Sales Analysis: 2004-2005 (In US$ million)
- Table 65: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)
43. MDS Pharma Services (USA)
44. Metrigenix, Inc. (USA)
45. Micronit Microfluidics BV (The Netherlands)
46. Mitsubishi Rayon Co., Ltd. (Japan)
47. Mobidiag Oy (Finland)
48. Motorola Biochip System (USA)
49. MWG Biotech AG (Germany)
- Table 66: First Quarter Sales Analysis: 2004-2005 (Q1) (In € million)
50. Nanogen, Inc. (USA)
51. Nimblegen Systems, Inc. (USA)
52. Nisshinbo Industries, Inc. (Japan)
- Table 67: Annual Sales Analysis: 2004-2005 (In ¥ million)
- Table 68: Annual Sales Analysis by Business Segment: 2004-2005 (In ¥ million)
- Table 69: Annual Sales Analysis by Geographical Region: 2004-2005 (In ¥ million)
53. Ocimum Biosolutions LLC (USA)
54. Origene Technologies, Inc. (USA)
55. Oxford Gene Technology (UK)
56. Perkinelmer, Inc. (USA)
- Perkinelmer Life Sciences (USA)
57. Procognia Limited (UK)
58. Qiagen NV (The Netherlands)
- Qiagen, Inc. (USA)
59. Randox Laboratories Ltd. (UK)
60. Samsung Advanced Institute Of Technology (Korea)
61. Scandinavian Micro Biodevices A/S (Denmark)
62. Sequenom, Inc. (USA)
63. Takara Bio, Inc. (Japan)
- Table 70: Annual Sales Analysis: 2004-2005 (In ¥ billion)
- Clontech Laboratories, Inc. (USA)
- Takara Bio Europe SA (France)
64. Telechem International, Inc. (USA)
65. TM Bioscience (Canada)
66. Toray Industries, Inc. (Japan)
- Table 71: Annual Sales Analysis: 2004-2005 (In ¥ billion)
- Table 72: Annual Sales Analysis By Business Segments: 2004-2005 (In ¥ billion)
- Table 73: Annual Sales Analysis By Geographical Regions: 2004-2005 (In ¥ billion)
67. Toshiba Corporation (Japan)
- Table 74: Annual Sales Analysis: 2004-2005 (In Us$ Billion)
68. Zyomyx, Inc. (USA)
|
如果这份报告还不能满足您的需求，或者您对这份报告还有什么意见或者建议，请您填写以下反馈信息。
|
|